GPhC Warns Superintendent Pharmacist Over Unsafe Amitriptyline Supply to Vulnerable Patients

Date of Decision: February 3, 2026

Registrant's Role: Pharmacist

Allegations:

  • Oversight of online prescriptions for amitriptyline to vulnerable patients without verifying medical information.
  • Failure to ensure contact with patients’ GPs regarding medication suitability.
  • Inadequate safeguarding procedures and risk consideration in online prescribing.
  • Failure to ensure appropriate clinical governance and duty of care in distance-selling pharmacy model.

Outcome: Warning issued and published on the GPhC register for 12 months

GPhC Standards Breached:

  • Standard 1 – Pharmacy professionals must provide person-centred care
  • Standard 2 – Pharmacy professionals must work in partnership with others
  • Standard 3 – Pharmacy professionals must communicate effectively
  • Standard 5 – Pharmacy professionals must use their professional judgement
  • Standard 8 – Pharmacy professionals must speak up when they have concerns or when things go wrong
  • Standard 9 – Pharmacy professionals must demonstrate leadership

Case Summary

Allegations

This case centers on the registrant, a Superintendent and Responsible Pharmacist, who also served as a Director at companies offering online pharmacy services. The companies operated under a distance-selling model and employed Pharmacist Independent Prescribers (PIPs) to review online questionnaires submitted by patients seeking medication.

The GPhC investigated allegations concerning the prescribing and supply of amitriptyline—a tricyclic antidepressant with sedative properties and known overdose risks—to two particularly vulnerable patients (referred to as Patients A and B). Both patients were already under the care of their GPs due to significant risks of overdose and self-harm.

Continue Reading the Full Case

This case was published more than two weeks ago. A premium subscription is required to read the complete case summary.

  • Full allegations considered by the GPhC/PSNI
  • Panel findings and reasoning
  • Outcome of the investigation
  • Sanctions considered and imposed on the Pharmacist
  • Key professional learning points

Become a Premium Subscriber or Log In

Original Case Document

The original determination document is available to registered users.

Register for Free or Log In

Leave a Reply